These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 2754424

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Can an intracavernous papaverine injection be used to diagnose arteriogenic impotence?
    Imagawa A, Kawanishi Y.
    Hinyokika Kiyo; 1988 Jul; 34(7):1185-9. PubMed ID: 3177140
    [Abstract] [Full Text] [Related]

  • 5. [Investigation of intracavernous injection of papaverine for erectile impotence].
    Takimoto Y, Kawazoe K, Hosokawa H, Hamada T, Ono M, Aoki Y, Yasuoka S.
    Hinyokika Kiyo; 1989 Jan; 35(1):71-6. PubMed ID: 2729023
    [Abstract] [Full Text] [Related]

  • 6. Nocturnal penile tumescence predicting response to intracorporeal pharmacological erection testing.
    Allen RP, Brendler CB.
    J Urol; 1988 Sep; 140(3):518-22. PubMed ID: 3411665
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [P.I.C.: the intracavernous injection of papaverine, a diagnostic test in impotence].
    Zbranca E.
    Rev Med Chir Soc Med Nat Iasi; 1988 Sep; 92(3):589-92. PubMed ID: 3249874
    [No Abstract] [Full Text] [Related]

  • 9. Intracavernous self-injection therapy for the treatment of erectile dysfunction.
    Chiang HS, Wen TC, Wu CC, Chiang WH.
    J Formos Med Assoc; 1992 Sep; 91(9):898-901. PubMed ID: 1363391
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Diagnosis and therapy of erectile impotence with special reference to papaverine].
    Schnyder von Wartensee M, Studer UE.
    Schweiz Med Wochenschr; 1986 Jul 26; 116(30):994-9. PubMed ID: 3529377
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Evaluation of impotence: intracorporeal injection of papaverine by color duplex sonography].
    Liu LC, Liu LH, Chiang CP, Huang CH, Wu CC, Wu DK, Chou YH, Chen LM.
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1989 Aug 26; 5(8):453-8. PubMed ID: 2687483
    [Abstract] [Full Text] [Related]

  • 16. [Priapism as a complication following diagnostic papaverine test].
    Darewicz J, Galek L.
    Z Urol Nephrol; 1989 Jun 26; 82(6):317-9. PubMed ID: 2763728
    [Abstract] [Full Text] [Related]

  • 17. Papaverine-phentolamine and prostaglandin E1 versus papaverine-phentolamine alone for intracorporeal injection therapy: a clinical double-blind study.
    Shenfeld O, Hanani J, Shalhav A, Vardi Y, Goldwasser B.
    J Urol; 1995 Sep 26; 154(3):1017-9. PubMed ID: 7637045
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Diagnostic intracorporeal papaverine injection].
    Liu LH.
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1988 Feb 26; 4(2):99-102. PubMed ID: 3163017
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.